1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Pipeline Drugs 1.2.3 Chemotherapy Drugs 1.2.4 Chemotherapy Regimens 1.3 Market by Application 1.3.1 Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Home Care 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Acute Myeloid Leukemia Therapeutics Market Perspective (2016-2027) 2.2 Acute Myeloid Leukemia Therapeutics Growth Trends by Regions 2.2.1 Acute Myeloid Leukemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Acute Myeloid Leukemia Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Acute Myeloid Leukemia Therapeutics Industry Dynamic 2.3.1 Acute Myeloid Leukemia Therapeutics Market Trends 2.3.2 Acute Myeloid Leukemia Therapeutics Market Drivers 2.3.3 Acute Myeloid Leukemia Therapeutics Market Challenges 2.3.4 Acute Myeloid Leukemia Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Revenue 3.1.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Acute Myeloid Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Acute Myeloid Leukemia Therapeutics Revenue 3.4 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio 3.4.1 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Therapeutics Revenue in 2020 3.5 Acute Myeloid Leukemia Therapeutics Key Players Head office and Area Served 3.6 Key Players Acute Myeloid Leukemia Therapeutics Product Solution and Service 3.7 Date of Enter into Acute Myeloid Leukemia Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Acute Myeloid Leukemia Therapeutics Breakdown Data by Type 4.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2022-2027) 5 Acute Myeloid Leukemia Therapeutics Breakdown Data by Application 5.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Acute Myeloid Leukemia Therapeutics Market Size (2016-2027) 6.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Type 6.2.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027) 6.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Application 6.3.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027) 6.4 North America Acute Myeloid Leukemia Therapeutics Market Size by Country 6.4.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Acute Myeloid Leukemia Therapeutics Market Size (2016-2027) 7.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type 7.2.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027) 7.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application 7.3.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027) 7.4 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country 7.4.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type 8.2.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application 8.3.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region 8.4.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size (2016-2027) 9.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type 9.2.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application 9.3.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country 9.4.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type 10.2.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application 10.3.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country 10.4.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Ambit Biosciences Corporation 11.1.1 Ambit Biosciences Corporation Company Details 11.1.2 Ambit Biosciences Corporation Business Overview 11.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Introduction 11.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) 11.1.5 Ambit Biosciences Corporation Recent Development 11.2 Genzyme Corporation Celgene Corporation 11.2.1 Genzyme Corporation Celgene Corporation Company Details 11.2.2 Genzyme Corporation Celgene Corporation Business Overview 11.2.3 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Introduction 11.2.4 Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) 11.2.5 Genzyme Corporation Celgene Corporation Recent Development 11.3 Clavis Pharma ASA 11.3.1 Clavis Pharma ASA Company Details 11.3.2 Clavis Pharma ASA Business Overview 11.3.3 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Introduction 11.3.4 Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) 11.3.5 Clavis Pharma ASA Recent Development 11.4 Sunesis Pharmaceuticals 11.4.1 Sunesis Pharmaceuticals Company Details 11.4.2 Sunesis Pharmaceuticals Business Overview 11.4.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Introduction 11.4.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) 11.4.5 Sunesis Pharmaceuticals Recent Development 11.5 Cephalon 11.5.1 Cephalon Company Details 11.5.2 Cephalon Business Overview 11.5.3 Cephalon Acute Myeloid Leukemia Therapeutics Introduction 11.5.4 Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) 11.5.5 Cephalon Recent Development 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Company Details 11.6.2 Bristol-Myers Squibb Business Overview 11.6.3 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Introduction 11.6.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) 11.6.5 Bristol-Myers Squibb Recent Development 11.7 Novartis International AG 11.7.1 Novartis International AG Company Details 11.7.2 Novartis International AG Business Overview 11.7.3 Novartis International AG Acute Myeloid Leukemia Therapeutics Introduction 11.7.4 Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) 11.7.5 Novartis International AG Recent Development 11.8 GlaxoSmithKline 11.8.1 GlaxoSmithKline Company Details 11.8.2 GlaxoSmithKline Business Overview 11.8.3 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Introduction 11.8.4 GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) 11.8.5 GlaxoSmithKline Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Pipeline Drugs Table 3. Key Players of Chemotherapy Drugs Table 4. Key Players of Chemotherapy Regimens Table 5. Global Acute Myeloid Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Acute Myeloid Leukemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Acute Myeloid Leukemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2016-2021) Table 9. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2022-2027) Table 11. Acute Myeloid Leukemia Therapeutics Market Trends Table 12. Acute Myeloid Leukemia Therapeutics Market Drivers Table 13. Acute Myeloid Leukemia Therapeutics Market Challenges Table 14. Acute Myeloid Leukemia Therapeutics Market Restraints Table 15. Global Acute Myeloid Leukemia Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Acute Myeloid Leukemia Therapeutics Market Share by Players (2016-2021) Table 17. Global Top Acute Myeloid Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2020) Table 18. Ranking of Global Top Acute Myeloid Leukemia Therapeutics Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Acute Myeloid Leukemia Therapeutics Product Solution and Service Table 22. Date of Enter into Acute Myeloid Leukemia Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 25. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2016-2021) Table 26. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Acute Myeloid Leukemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Application (2016-2021) Table 30. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 33. North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 35. North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 62. Ambit Biosciences Corporation Company Details Table 63. Ambit Biosciences Corporation Business Overview Table 64. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Product Table 65. Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 66. Ambit Biosciences Corporation Recent Development Table 67. Genzyme Corporation Celgene Corporation Company Details Table 68. Genzyme Corporation Celgene Corporation Business Overview Table 69. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Product Table 70. Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 71. Genzyme Corporation Celgene Corporation Recent Development Table 72. Clavis Pharma ASA Company Details Table 73. Clavis Pharma ASA Business Overview Table 74. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Product Table 75. Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 76. Clavis Pharma ASA Recent Development Table 77. Sunesis Pharmaceuticals Company Details Table 78. Sunesis Pharmaceuticals Business Overview Table 79. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Product Table 80. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 81. Sunesis Pharmaceuticals Recent Development Table 82. Cephalon Company Details Table 83. Cephalon Business Overview Table 84. Cephalon Acute Myeloid Leukemia Therapeutics Product Table 85. Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 86. Cephalon Recent Development Table 87. Bristol-Myers Squibb Company Details Table 88. Bristol-Myers Squibb Business Overview Table 89. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Product Table 90. Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 91. Bristol-Myers Squibb Recent Development Table 92. Novartis International AG Company Details Table 93. Novartis International AG Business Overview Table 94. Novartis International AG Acute Myeloid Leukemia Therapeutics Product Table 95. Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 96. Novartis International AG Recent Development Table 97. GlaxoSmithKline Company Details Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million) Table 100. GlaxoSmithKline Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Acute Myeloid Leukemia Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Pipeline Drugs Features Figure 3. Chemotherapy Drugs Features Figure 4. Chemotherapy Regimens Features Figure 5. Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Home Care Case Studies Figure 9. Acute Myeloid Leukemia Therapeutics Report Years Considered Figure 10. Global Acute Myeloid Leukemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Acute Myeloid Leukemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions: 2020 VS 2027 Figure 13. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2022-2027) Figure 14. Global Acute Myeloid Leukemia Therapeutics Market Share by Players in 2020 Figure 15. Global Top Acute Myeloid Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue in 2020 Figure 17. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2016-2021) Figure 18. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2022-2027) Figure 19. North America Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027) Figure 21. North America Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027) Figure 22. North America Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027) Figure 23. United States Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027) Figure 27. Europe Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027) Figure 28. Europe Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027) Figure 29. Germany Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027) Figure 37. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027) Figure 38. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Share by Region (2016-2027) Figure 39. China Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027) Figure 47. Latin America Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027) Figure 48. Latin America Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027) Figure 49. Mexico Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027) Figure 53. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027) Figure 54. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027) Figure 55. Turkey Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Ambit Biosciences Corporation Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021) Figure 59. Genzyme Corporation Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021) Figure 60. Clavis Pharma ASA Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021) Figure 61. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021) Figure 62. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021) Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021) Figure 64. Novartis International AG Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021) Figure 65. GlaxoSmithKline Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Ambit Biosciences Corporation Genzyme Corporation Celgene Corporation Clavis Pharma ASA Sunesis Pharmaceuticals Cephalon Bristol-Myers Squibb Novartis International AG GlaxoSmithKline